Dysregulated expression of ZNF667-AS1 has been reported in many tumors, including breast cancer, cervical cancer, laryngeal squamous cell carcinoma, and esophageal squamous cell carcinoma [45–48]. Here, ZNF667 is linked to breast carcinoma.